- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 92.5M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$8.62M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$16.46M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $1.82B |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $1.67B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $524.43M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $545.49M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$317.68M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$49.08M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.16B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.9B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.18B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.92B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $670.16M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $629.46M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.88B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.89B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.20 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.32 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.20 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.32 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$294.14M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$29.48M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$16.69M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$17.28M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $51.67M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $41.55M |
| Revenue | Q1 2026 · Mar 31, 2026 | $63.62M |
| Revenue | Q1 2026 · Mar 31, 2025 | $47.06M |